| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 82 | 2023 | 1384 | 11.190 |
Why?
|
| Endovascular Procedures | 82 | 2023 | 1973 | 9.250 |
Why?
|
| Aortic Aneurysm, Thoracic | 51 | 2023 | 685 | 8.510 |
Why?
|
| Aortic Aneurysm, Abdominal | 56 | 2023 | 1181 | 7.820 |
Why?
|
| Blood Vessel Prosthesis | 60 | 2023 | 933 | 7.090 |
Why?
|
| Stents | 38 | 2023 | 3276 | 3.180 |
Why?
|
| Aortic Aneurysm | 18 | 2020 | 643 | 2.970 |
Why?
|
| Prosthesis Design | 49 | 2023 | 2110 | 2.740 |
Why?
|
| Spinal Cord Ischemia | 10 | 2023 | 93 | 2.680 |
Why?
|
| Vascular Surgical Procedures | 20 | 2023 | 1473 | 2.420 |
Why?
|
| Iliac Aneurysm | 6 | 2020 | 38 | 1.960 |
Why?
|
| Aortic Diseases | 12 | 2022 | 741 | 1.840 |
Why?
|
| Aortography | 28 | 2017 | 431 | 1.590 |
Why?
|
| Aorta, Thoracic | 10 | 2021 | 1080 | 1.530 |
Why?
|
| Aortic Rupture | 8 | 2022 | 310 | 1.530 |
Why?
|
| Ohio | 22 | 2020 | 337 | 1.410 |
Why?
|
| Iliac Artery | 8 | 2020 | 364 | 1.400 |
Why?
|
| Endoleak | 14 | 2023 | 101 | 1.360 |
Why?
|
| Vascular Patency | 16 | 2020 | 885 | 1.300 |
Why?
|
| Aorta, Abdominal | 7 | 2023 | 645 | 1.280 |
Why?
|
| Endarterectomy, Carotid | 9 | 2023 | 546 | 1.130 |
Why?
|
| Aneurysm | 7 | 2023 | 339 | 1.100 |
Why?
|
| Postoperative Complications | 45 | 2023 | 15244 | 1.020 |
Why?
|
| Subclavian Artery | 4 | 2021 | 129 | 1.010 |
Why?
|
| Treatment Outcome | 96 | 2023 | 62966 | 0.990 |
Why?
|
| Arterial Occlusive Diseases | 11 | 2020 | 793 | 0.950 |
Why?
|
| Angioplasty, Balloon | 6 | 2020 | 653 | 0.930 |
Why?
|
| Time Factors | 70 | 2023 | 40054 | 0.920 |
Why?
|
| Graft Occlusion, Vascular | 8 | 2021 | 548 | 0.800 |
Why?
|
| Risk Factors | 85 | 2023 | 72145 | 0.780 |
Why?
|
| Renal Artery | 4 | 2019 | 398 | 0.780 |
Why?
|
| Peripheral Vascular Diseases | 5 | 2023 | 550 | 0.700 |
Why?
|
| Matrix Metalloproteinase 9 | 8 | 2012 | 638 | 0.680 |
Why?
|
| Device Removal | 4 | 2018 | 652 | 0.670 |
Why?
|
| Congresses as Topic | 2 | 2020 | 764 | 0.640 |
Why?
|
| Risk Assessment | 42 | 2022 | 23320 | 0.630 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 2016 | 89 | 0.630 |
Why?
|
| Angiotensin II | 3 | 2012 | 881 | 0.620 |
Why?
|
| Biomedical Research | 4 | 2022 | 3306 | 0.610 |
Why?
|
| Vascular Diseases | 4 | 2022 | 1155 | 0.590 |
Why?
|
| Retrospective Studies | 71 | 2023 | 77098 | 0.580 |
Why?
|
| Aged, 80 and over | 54 | 2023 | 57683 | 0.580 |
Why?
|
| Prosthesis Failure | 8 | 2015 | 1203 | 0.570 |
Why?
|
| Reoperation | 18 | 2020 | 4200 | 0.560 |
Why?
|
| Aged | 96 | 2023 | 162944 | 0.560 |
Why?
|
| Carotid Stenosis | 6 | 2020 | 854 | 0.550 |
Why?
|
| Hypoalbuminemia | 1 | 2017 | 87 | 0.550 |
Why?
|
| Retreatment | 6 | 2021 | 604 | 0.530 |
Why?
|
| Kaplan-Meier Estimate | 16 | 2017 | 6534 | 0.520 |
Why?
|
| Aorta | 11 | 2023 | 2057 | 0.510 |
Why?
|
| Humans | 163 | 2023 | 742088 | 0.460 |
Why?
|
| Pelvis | 2 | 2017 | 730 | 0.450 |
Why?
|
| Databases, Factual | 17 | 2021 | 7716 | 0.440 |
Why?
|
| Matrix Metalloproteinase 2 | 5 | 2012 | 472 | 0.440 |
Why?
|
| Chi-Square Distribution | 12 | 2016 | 3510 | 0.440 |
Why?
|
| Male | 115 | 2023 | 349538 | 0.420 |
Why?
|
| STAT1 Transcription Factor | 2 | 2011 | 320 | 0.420 |
Why?
|
| Forecasting | 1 | 2021 | 2948 | 0.420 |
Why?
|
| Interleukin-5 | 1 | 2012 | 273 | 0.400 |
Why?
|
| Femoral Artery | 3 | 2020 | 843 | 0.390 |
Why?
|
| Apolipoproteins E | 3 | 2012 | 1438 | 0.380 |
Why?
|
| Urinary Retention | 2 | 2023 | 110 | 0.380 |
Why?
|
| STAT Transcription Factors | 1 | 2011 | 182 | 0.380 |
Why?
|
| Female | 104 | 2023 | 379592 | 0.370 |
Why?
|
| Physicians, Women | 3 | 2022 | 487 | 0.360 |
Why?
|
| Viscera | 1 | 2010 | 139 | 0.350 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 2283 | 0.340 |
Why?
|
| Vascular Grafting | 3 | 2020 | 142 | 0.340 |
Why?
|
| Lower Extremity | 5 | 2022 | 1151 | 0.340 |
Why?
|
| Ischemia | 4 | 2018 | 1911 | 0.330 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2187 | 0.330 |
Why?
|
| Pancreatic Elastase | 4 | 2005 | 135 | 0.310 |
Why?
|
| Laparotomy | 2 | 2020 | 474 | 0.310 |
Why?
|
| Middle Aged | 67 | 2023 | 213127 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 31 | 2023 | 20086 | 0.300 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 1952 | 0.300 |
Why?
|
| Hematoma | 4 | 2022 | 755 | 0.300 |
Why?
|
| Societies, Medical | 2 | 2020 | 3740 | 0.290 |
Why?
|
| Cardiology | 1 | 2018 | 1658 | 0.290 |
Why?
|
| Vascular Malformations | 1 | 2012 | 450 | 0.290 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2006 | 61 | 0.280 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2010 | 577 | 0.270 |
Why?
|
| Inguinal Canal | 1 | 2006 | 69 | 0.270 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3130 | 0.260 |
Why?
|
| Coronary Artery Bypass | 3 | 2019 | 2281 | 0.260 |
Why?
|
| Thrombosis | 6 | 2022 | 2966 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3236 | 0.260 |
Why?
|
| Prospective Studies | 21 | 2023 | 53187 | 0.250 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 689 | 0.250 |
Why?
|
| Aneurysm, False | 2 | 2017 | 276 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2006 | 1213 | 0.240 |
Why?
|
| Fluoroscopy | 3 | 2022 | 924 | 0.240 |
Why?
|
| Pandemics | 3 | 2020 | 8328 | 0.240 |
Why?
|
| Venous Thrombosis | 3 | 2020 | 1237 | 0.240 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2005 | 365 | 0.230 |
Why?
|
| Marfan Syndrome | 2 | 2023 | 240 | 0.230 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1889 | 0.230 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2023 | 40 | 0.230 |
Why?
|
| omega-N-Methylarginine | 2 | 2002 | 111 | 0.230 |
Why?
|
| Splenic Artery | 1 | 2023 | 53 | 0.220 |
Why?
|
| Spinal Cord Injuries | 2 | 2023 | 930 | 0.220 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 602 | 0.210 |
Why?
|
| Treatment Failure | 6 | 2020 | 2615 | 0.210 |
Why?
|
| Popliteal Artery | 3 | 2008 | 317 | 0.200 |
Why?
|
| Peripheral Arterial Disease | 3 | 2021 | 1184 | 0.200 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1517 | 0.200 |
Why?
|
| Renin-Angiotensin System | 1 | 2005 | 759 | 0.190 |
Why?
|
| Mesenteric Veins | 1 | 2021 | 89 | 0.190 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2017 | 1183 | 0.190 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 848 | 0.190 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 264 | 0.190 |
Why?
|
| Aortic Valve | 1 | 2010 | 1911 | 0.190 |
Why?
|
| Arteritis | 1 | 2002 | 159 | 0.180 |
Why?
|
| Diverticulum | 1 | 2021 | 136 | 0.180 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 156 | 0.180 |
Why?
|
| Tunica Intima | 1 | 2002 | 464 | 0.180 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2021 | 205 | 0.180 |
Why?
|
| Stroke | 6 | 2022 | 9963 | 0.180 |
Why?
|
| Hyperplasia | 2 | 2002 | 1183 | 0.180 |
Why?
|
| Venous Insufficiency | 1 | 2021 | 103 | 0.180 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2022 | 4029 | 0.170 |
Why?
|
| Image Enhancement | 1 | 2010 | 2921 | 0.170 |
Why?
|
| Incidence | 9 | 2021 | 20928 | 0.170 |
Why?
|
| Patient Selection | 5 | 2017 | 4214 | 0.170 |
Why?
|
| Angiography | 4 | 2010 | 1636 | 0.170 |
Why?
|
| Menopause, Premature | 1 | 2020 | 132 | 0.170 |
Why?
|
| Hospital Mortality | 9 | 2023 | 5310 | 0.170 |
Why?
|
| Cytokines | 2 | 2012 | 7317 | 0.170 |
Why?
|
| Odds Ratio | 7 | 2017 | 9846 | 0.170 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2011 | 97 | 0.170 |
Why?
|
| Brachial Artery | 1 | 2020 | 370 | 0.170 |
Why?
|
| United States | 24 | 2023 | 69693 | 0.170 |
Why?
|
| Blood Group Antigens | 1 | 2020 | 179 | 0.170 |
Why?
|
| Authorship | 1 | 2022 | 271 | 0.160 |
Why?
|
| Polytetrafluoroethylene | 1 | 1999 | 233 | 0.160 |
Why?
|
| Regional Health Planning | 1 | 2019 | 97 | 0.160 |
Why?
|
| Sex Factors | 7 | 2022 | 10392 | 0.160 |
Why?
|
| Versicans | 1 | 2018 | 33 | 0.160 |
Why?
|
| Sexual Harassment | 1 | 2019 | 79 | 0.160 |
Why?
|
| Multivariate Analysis | 7 | 2017 | 12242 | 0.160 |
Why?
|
| Physician Executives | 1 | 2019 | 128 | 0.160 |
Why?
|
| Intraoperative Care | 2 | 2020 | 766 | 0.160 |
Why?
|
| Aggrecans | 1 | 2018 | 90 | 0.160 |
Why?
|
| Ultrasonography, Doppler | 1 | 2020 | 458 | 0.160 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2022 | 448 | 0.160 |
Why?
|
| Professional Practice | 1 | 2020 | 326 | 0.160 |
Why?
|
| Surgery Department, Hospital | 1 | 2019 | 175 | 0.150 |
Why?
|
| Cultural Competency | 1 | 2020 | 288 | 0.150 |
Why?
|
| RNA, Messenger | 11 | 2018 | 13029 | 0.150 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
| Specialties, Surgical | 1 | 2022 | 389 | 0.150 |
Why?
|
| Down-Regulation | 3 | 2017 | 3001 | 0.150 |
Why?
|
| Severity of Illness Index | 9 | 2021 | 15530 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2012 | 1504 | 0.150 |
Why?
|
| Cultural Diversity | 1 | 2020 | 358 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 3 | 2010 | 1483 | 0.150 |
Why?
|
| Hypotension | 1 | 2023 | 880 | 0.150 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 344 | 0.150 |
Why?
|
| Nitric Oxide | 3 | 2002 | 2128 | 0.140 |
Why?
|
| Occupational Exposure | 2 | 2020 | 1794 | 0.140 |
Why?
|
| Regional Blood Flow | 2 | 2017 | 1525 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 1 | 2022 | 934 | 0.140 |
Why?
|
| Length of Stay | 8 | 2023 | 6294 | 0.140 |
Why?
|
| Workplace | 2 | 2020 | 836 | 0.140 |
Why?
|
| Collagen Type III | 1 | 2016 | 90 | 0.140 |
Why?
|
| Lipoprotein(a) | 1 | 2020 | 425 | 0.140 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 6891 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2012 | 8300 | 0.140 |
Why?
|
| Elephants | 1 | 2016 | 36 | 0.140 |
Why?
|
| Clinical Trials as Topic | 5 | 2020 | 7901 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3507 | 0.140 |
Why?
|
| Atherosclerosis | 2 | 2010 | 3428 | 0.130 |
Why?
|
| Terminally Ill | 1 | 2017 | 238 | 0.130 |
Why?
|
| Online Systems | 1 | 2016 | 184 | 0.130 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2013 | 341 | 0.120 |
Why?
|
| Predictive Value of Tests | 6 | 2016 | 15056 | 0.120 |
Why?
|
| Specialization | 1 | 2019 | 777 | 0.120 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 3151 | 0.120 |
Why?
|
| Radiography, Interventional | 2 | 2013 | 1095 | 0.120 |
Why?
|
| Inflammation | 2 | 2012 | 10578 | 0.120 |
Why?
|
| Feasibility Studies | 4 | 2017 | 5062 | 0.120 |
Why?
|
| Patient Care | 1 | 2020 | 639 | 0.120 |
Why?
|
| Leg | 2 | 2008 | 1110 | 0.120 |
Why?
|
| Hospitals, Teaching | 1 | 2019 | 1179 | 0.120 |
Why?
|
| Anastomosis, Surgical | 3 | 2019 | 985 | 0.120 |
Why?
|
| Women's Health | 2 | 2020 | 2034 | 0.120 |
Why?
|
| Foreign-Body Migration | 3 | 2013 | 221 | 0.120 |
Why?
|
| Aortitis | 1 | 2014 | 73 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2002 | 1911 | 0.120 |
Why?
|
| Nutrition Assessment | 1 | 2017 | 723 | 0.120 |
Why?
|
| Mice, Knockout | 6 | 2018 | 14554 | 0.120 |
Why?
|
| Operating Room Nursing | 1 | 2013 | 26 | 0.120 |
Why?
|
| Acute Disease | 7 | 2021 | 7141 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 8925 | 0.110 |
Why?
|
| Leadership | 2 | 2020 | 1357 | 0.110 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 12344 | 0.110 |
Why?
|
| Pulmonary Embolism | 2 | 2004 | 2370 | 0.110 |
Why?
|
| Dyslipidemias | 1 | 2020 | 848 | 0.110 |
Why?
|
| Vascular System Injuries | 1 | 2016 | 250 | 0.110 |
Why?
|
| Acute Kidney Injury | 3 | 2023 | 1967 | 0.110 |
Why?
|
| Peritoneal Cavity | 1 | 2012 | 148 | 0.110 |
Why?
|
| Collateral Circulation | 1 | 2013 | 287 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2002 | 3800 | 0.100 |
Why?
|
| Vertebral Artery | 1 | 2013 | 192 | 0.100 |
Why?
|
| Rats | 12 | 2012 | 24265 | 0.100 |
Why?
|
| Celiac Artery | 3 | 2013 | 68 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2013 | 314 | 0.100 |
Why?
|
| Dilatation, Pathologic | 2 | 2010 | 520 | 0.100 |
Why?
|
| Embolization, Therapeutic | 4 | 2016 | 1392 | 0.100 |
Why?
|
| Comorbidity | 4 | 2021 | 10372 | 0.100 |
Why?
|
| Mesenteric Artery, Superior | 3 | 2013 | 101 | 0.100 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 1196 | 0.100 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 251 | 0.100 |
Why?
|
| Carotid Artery Diseases | 2 | 2010 | 882 | 0.100 |
Why?
|
| Chronic Disease | 8 | 2021 | 9144 | 0.100 |
Why?
|
| Education, Medical | 2 | 2020 | 1717 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2019 | 1182 | 0.090 |
Why?
|
| STAT5 Transcription Factor | 1 | 2011 | 259 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1431 | 0.090 |
Why?
|
| Burnout, Professional | 1 | 2019 | 690 | 0.090 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4187 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2018 | 1807 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 3067 | 0.090 |
Why?
|
| Age Factors | 6 | 2021 | 18355 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 2 | 2004 | 916 | 0.090 |
Why?
|
| Nursing Staff, Hospital | 1 | 2013 | 346 | 0.090 |
Why?
|
| Politics | 1 | 2016 | 790 | 0.090 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 1369 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2011 | 8436 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6365 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2021 | 1794 | 0.090 |
Why?
|
| Life Tables | 3 | 2010 | 370 | 0.080 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 603 | 0.080 |
Why?
|
| Animals | 19 | 2018 | 168561 | 0.080 |
Why?
|
| Wound Healing | 1 | 2020 | 2781 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2016 | 742 | 0.080 |
Why?
|
| Registries | 6 | 2021 | 8077 | 0.080 |
Why?
|
| Vasoconstrictor Agents | 1 | 2012 | 643 | 0.080 |
Why?
|
| Interleukin-10 | 2 | 2012 | 1200 | 0.080 |
Why?
|
| Vasculitis | 1 | 2012 | 521 | 0.080 |
Why?
|
| Michigan | 2 | 2006 | 350 | 0.080 |
Why?
|
| Radiation Dosage | 2 | 2013 | 1927 | 0.080 |
Why?
|
| Attitude of Health Personnel | 2 | 2019 | 3839 | 0.080 |
Why?
|
| Patient Transfer | 1 | 2014 | 760 | 0.080 |
Why?
|
| Medicine | 1 | 2016 | 941 | 0.070 |
Why?
|
| Mesenteric Artery, Inferior | 2 | 2008 | 15 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 874 | 0.070 |
Why?
|
| Th1 Cells | 1 | 2012 | 1056 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3210 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2012 | 1049 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2019 | 4681 | 0.070 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 18006 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2019 | 3300 | 0.070 |
Why?
|
| Operating Rooms | 1 | 2013 | 813 | 0.070 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2009 | 277 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2017 | 4197 | 0.070 |
Why?
|
| Hospitals, Military | 1 | 2006 | 67 | 0.070 |
Why?
|
| Prognosis | 5 | 2021 | 29010 | 0.070 |
Why?
|
| Nitroso Compounds | 1 | 2006 | 72 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2017 | 2145 | 0.070 |
Why?
|
| Syndrome | 2 | 2014 | 3248 | 0.070 |
Why?
|
| Nitric Oxide Donors | 1 | 2006 | 121 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2005 | 149 | 0.070 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 957 | 0.070 |
Why?
|
| Phenotype | 4 | 2016 | 16331 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2012 | 3038 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2016 | 17400 | 0.060 |
Why?
|
| L-Selectin | 1 | 2005 | 213 | 0.060 |
Why?
|
| Carotid Artery, External | 1 | 2004 | 38 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4566 | 0.060 |
Why?
|
| Learning Curve | 2 | 2017 | 200 | 0.060 |
Why?
|
| Catalase | 1 | 2005 | 222 | 0.060 |
Why?
|
| Adult | 17 | 2023 | 213712 | 0.060 |
Why?
|
| Perfusion | 2 | 2005 | 1359 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2005 | 129 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2019 | 6078 | 0.060 |
Why?
|
| Hospitals, University | 1 | 2006 | 571 | 0.060 |
Why?
|
| Emergencies | 3 | 2016 | 1164 | 0.060 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2004 | 134 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4751 | 0.060 |
Why?
|
| Hemorrhage | 2 | 2014 | 3461 | 0.060 |
Why?
|
| Thrombophlebitis | 2 | 2001 | 309 | 0.060 |
Why?
|
| Decision Making | 1 | 2017 | 3869 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2008 | 604 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2013 | 2924 | 0.060 |
Why?
|
| Aneurysm, Dissecting | 1 | 2002 | 11 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 802 | 0.060 |
Why?
|
| Anesthesiology | 1 | 2013 | 1043 | 0.060 |
Why?
|
| Hypertension | 1 | 2023 | 8455 | 0.060 |
Why?
|
| Thrombolytic Therapy | 2 | 2011 | 2161 | 0.060 |
Why?
|
| Propensity Score | 2 | 2020 | 1771 | 0.060 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 39004 | 0.050 |
Why?
|
| Recurrence | 3 | 2011 | 8333 | 0.050 |
Why?
|
| Popliteal Vein | 1 | 2002 | 43 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3862 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2012 | 19223 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2012 | 1877 | 0.050 |
Why?
|
| Saphenous Vein | 2 | 2013 | 531 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2005 | 675 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2005 | 390 | 0.050 |
Why?
|
| Gelatinases | 1 | 2002 | 94 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2004 | 317 | 0.050 |
Why?
|
| Evidence-Based Medicine | 3 | 2010 | 3611 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 176 | 0.050 |
Why?
|
| Femoral Vein | 1 | 2002 | 159 | 0.050 |
Why?
|
| Veins | 1 | 2006 | 769 | 0.050 |
Why?
|
| Nitrites | 1 | 2002 | 160 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 554 | 0.050 |
Why?
|
| Survival Rate | 6 | 2014 | 12773 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2006 | 889 | 0.050 |
Why?
|
| Logistic Models | 4 | 2021 | 13403 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 2267 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 10232 | 0.050 |
Why?
|
| E-Selectin | 1 | 2003 | 579 | 0.050 |
Why?
|
| P-Selectin | 1 | 2003 | 600 | 0.050 |
Why?
|
| Fibrin | 1 | 2003 | 506 | 0.050 |
Why?
|
| Mutation | 2 | 2016 | 29717 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2005 | 980 | 0.050 |
Why?
|
| Mice | 5 | 2012 | 81045 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 13853 | 0.040 |
Why?
|
| Sclerotherapy | 1 | 2021 | 175 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2002 | 2255 | 0.040 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 11690 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 686 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 6454 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 2022 | 800 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 689 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1520 | 0.040 |
Why?
|
| Punctures | 1 | 2020 | 372 | 0.040 |
Why?
|
| Urinary Catheterization | 1 | 2020 | 201 | 0.040 |
Why?
|
| Career Mobility | 1 | 2020 | 262 | 0.040 |
Why?
|
| Reference Values | 1 | 2005 | 4982 | 0.040 |
Why?
|
| Urodynamics | 1 | 2020 | 347 | 0.040 |
Why?
|
| Chemokines | 1 | 2002 | 954 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2009 | 2527 | 0.040 |
Why?
|
| Arteries | 1 | 2023 | 1118 | 0.040 |
Why?
|
| Tunica Media | 1 | 2018 | 113 | 0.040 |
Why?
|
| Paraplegia | 1 | 2018 | 168 | 0.040 |
Why?
|
| Rehabilitation Centers | 1 | 2019 | 254 | 0.040 |
Why?
|
| Kinetics | 1 | 2005 | 6474 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2022 | 648 | 0.040 |
Why?
|
| Ligation | 2 | 2013 | 453 | 0.040 |
Why?
|
| Boston | 2 | 2020 | 9305 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2020 | 510 | 0.040 |
Why?
|
| Anticoagulants | 2 | 2002 | 4595 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 2536 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2023 | 40450 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2020 | 773 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2001 | 633 | 0.030 |
Why?
|
| Disease Progression | 3 | 2022 | 13256 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 6171 | 0.030 |
Why?
|
| Survival Analysis | 2 | 1999 | 10248 | 0.030 |
Why?
|
| Neutrophils | 2 | 2005 | 3711 | 0.030 |
Why?
|
| Skilled Nursing Facilities | 1 | 2019 | 372 | 0.030 |
Why?
|
| Constriction, Pathologic | 2 | 2010 | 1095 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2004 | 2500 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15108 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2061 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2020 | 1459 | 0.030 |
Why?
|
| Regional Medical Programs | 1 | 2014 | 71 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 670 | 0.030 |
Why?
|
| Sweden | 1 | 2017 | 1343 | 0.030 |
Why?
|
| Warfarin | 1 | 2002 | 1493 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2020 | 1078 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2935 | 0.030 |
Why?
|
| Pedigree | 2 | 2013 | 4646 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 2019 | 1780 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.030 |
Why?
|
| Thoracic Surgery | 1 | 2020 | 713 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2043 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2900 | 0.030 |
Why?
|
| Protective Clothing | 1 | 2013 | 102 | 0.030 |
Why?
|
| Heredity | 1 | 2013 | 154 | 0.030 |
Why?
|
| Aneurysm, Ruptured | 1 | 1998 | 452 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2020 | 2451 | 0.030 |
Why?
|
| Radiation Monitoring | 1 | 2013 | 97 | 0.030 |
Why?
|
| Chile | 1 | 2013 | 237 | 0.030 |
Why?
|
| Medicare | 2 | 2020 | 6532 | 0.030 |
Why?
|
| New Zealand | 1 | 2013 | 357 | 0.030 |
Why?
|
| Mitochondria | 1 | 2005 | 3520 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 1661 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2011 | 5019 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2022 | 2506 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 21596 | 0.030 |
Why?
|
| Porosity | 1 | 2012 | 362 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2012 | 334 | 0.030 |
Why?
|
| Intestines | 1 | 2021 | 1923 | 0.030 |
Why?
|
| Publishing | 1 | 2019 | 833 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 1188 | 0.020 |
Why?
|
| Postmenopause | 1 | 2020 | 2461 | 0.020 |
Why?
|
| Inpatients | 1 | 2023 | 2495 | 0.020 |
Why?
|
| Polyesters | 1 | 2012 | 363 | 0.020 |
Why?
|
| South Africa | 1 | 2016 | 1728 | 0.020 |
Why?
|
| Linear Models | 2 | 2011 | 5948 | 0.020 |
Why?
|
| Embolectomy | 1 | 2011 | 120 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2795 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8297 | 0.020 |
Why?
|
| Pregnancy | 2 | 2023 | 29087 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2011 | 520 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2013 | 419 | 0.020 |
Why?
|
| Apoptosis | 1 | 2005 | 9715 | 0.020 |
Why?
|
| Respiratory Insufficiency | 2 | 2011 | 1199 | 0.020 |
Why?
|
| Contrast Media | 2 | 2013 | 5295 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 1831 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8621 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2010 | 333 | 0.020 |
Why?
|
| Equipment Design | 1 | 2016 | 3582 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 21821 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3738 | 0.020 |
Why?
|
| Tibial Arteries | 1 | 2008 | 57 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 538 | 0.020 |
Why?
|
| Benchmarking | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Internet | 1 | 2020 | 3062 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7276 | 0.020 |
Why?
|
| Embolism | 1 | 2011 | 409 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14720 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2009 | 425 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2009 | 475 | 0.020 |
Why?
|
| Occupational Health | 1 | 2013 | 809 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 11363 | 0.020 |
Why?
|
| Afghanistan | 1 | 2006 | 81 | 0.020 |
Why?
|
| Iraq | 1 | 2006 | 92 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 3339 | 0.020 |
Why?
|
| Catheterization | 2 | 2004 | 1468 | 0.020 |
Why?
|
| Vietnam Conflict | 1 | 2006 | 99 | 0.020 |
Why?
|
| Troponin T | 1 | 2011 | 749 | 0.020 |
Why?
|
| Thrombectomy | 1 | 2011 | 679 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2013 | 1178 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2005 | 5180 | 0.020 |
Why?
|
| Health Status | 1 | 2019 | 4030 | 0.020 |
Why?
|
| Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2005 | 188 | 0.020 |
Why?
|
| Phlebography | 1 | 2006 | 333 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 1740 | 0.020 |
Why?
|
| Technology Transfer | 1 | 2004 | 44 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 514 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13921 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 1484 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 23387 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 99 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2593 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 759 | 0.010 |
Why?
|
| Guanidines | 1 | 2004 | 191 | 0.010 |
Why?
|
| Health Care Sector | 1 | 2004 | 194 | 0.010 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2008 | 576 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15194 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 928 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 534 | 0.010 |
Why?
|
| Biomedical Technology | 1 | 2004 | 221 | 0.010 |
Why?
|
| Child | 3 | 2023 | 77478 | 0.010 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 110 | 0.010 |
Why?
|
| Tomography, Spiral Computed | 1 | 2003 | 279 | 0.010 |
Why?
|
| Radiography | 2 | 2004 | 7010 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2645 | 0.010 |
Why?
|
| Adolescent | 3 | 2023 | 85649 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9410 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2012 | 21719 | 0.010 |
Why?
|
| Young Adult | 2 | 2023 | 56350 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5724 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 1831 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2005 | 1099 | 0.010 |
Why?
|
| Calcinosis | 1 | 2010 | 1497 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2003 | 792 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 901 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 2027 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2004 | 1154 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 3701 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2003 | 400 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2003 | 1583 | 0.010 |
Why?
|
| Carotid Artery Injuries | 1 | 1999 | 96 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1801 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 1849 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 3915 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 24913 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2006 | 2739 | 0.010 |
Why?
|
| Fascia | 1 | 1998 | 135 | 0.010 |
Why?
|
| Microscopy | 1 | 2003 | 903 | 0.010 |
Why?
|
| Thigh | 1 | 1998 | 247 | 0.010 |
Why?
|
| Compartment Syndromes | 1 | 1998 | 153 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4211 | 0.010 |
Why?
|
| Ethanol | 1 | 2001 | 1337 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2009 | 40955 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 2400 | 0.010 |
Why?
|
| Monocytes | 1 | 2003 | 2593 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1999 | 2876 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 7790 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 19862 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 5978 | 0.010 |
Why?
|
| Macrophages | 1 | 2005 | 5655 | 0.010 |
Why?
|
| HIV Infections | 1 | 2016 | 16678 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 4455 | 0.010 |
Why?
|
| Anemia | 1 | 1998 | 1499 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 12071 | 0.000 |
Why?
|